Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
Détails
Télécharger: 33091381_BIB_6F92D71268C4.pdf (317.84 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
Etat: Public
Version: Final published version
Licence: Non spécifiée
ID Serval
serval:BIB_6F92D71268C4
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Editorial
Collection
Publications
Institution
Titre
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
Périodique
Cancer cell
ISSN
1878-3686 (Electronic)
ISSN-L
1535-6108
Statut éditorial
Publié
Date de publication
09/11/2020
Peer-reviewed
Oui
Volume
38
Numéro
5
Pages
602-604
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified several negative prognostic factors. In this commentary, we discuss the importance and limits of patient registries to support decision-making in thoracic cancer during the SARS-CoV-2 pandemic.
Mots-clé
Betacoronavirus/isolation & purification, COVID-19, Clinical Decision-Making, Coronavirus Infections/complications, Coronavirus Infections/virology, Global Burden of Disease/standards, Humans, International Cooperation, Pandemics, Pneumonia, Viral/complications, Pneumonia, Viral/virology, Practice Guidelines as Topic/standards, Registries, SARS-CoV-2, Thoracic Neoplasms/epidemiology, Thoracic Neoplasms/therapy, Thoracic Neoplasms/virology
Pubmed
Web of science
Open Access
Oui
Création de la notice
02/11/2020 13:40
Dernière modification de la notice
30/04/2021 6:11